Sanofi Pasteur shows efficacy of its dengue vaccine in phase 3.

Sanofi Pasteur shows efficacy of its dengue vaccine in phase 3 New glioblastoma vaccine: Safe and immunogenic in phase 1 FDA approves sublingual hay fever immunotherapeutic Combining the cancer vaccine DPX-Survivac with immune modulators Two Meningococcal B vaccines receive FDA ‚Breakthrough Therapy’ designation MERS vaccine is technically feasible, but is it commerically feasible? Stemline’s synthetic multi-peptide cancer vaccine enters Phase 2 Evolution of whooping cough bacterium may reduce vaccine effectiveness